Cargando…
Carbon-Ion Beam Irradiation Alone or in Combination with Zoledronic acid Effectively Kills Osteosarcoma Cells
Osteosarcoma (OSA) is the most common malignant bone tumor in children and adolescents. The overall five-year survival rate for all bone cancers is below 70%; however, when the cancer has spread beyond the bone, it is about 15–30%. Herein, we evaluated the effects of carbon-ion beam irradiation alon...
Autores principales: | Kim, Eun Ho, Kim, Mi-Sook, Takahashi, Akihisa, Suzuki, Masao, Vares, Guillaume, Uzawa, Akiko, Fujimori, Akira, Ohno, Tatsuya, Sai, Sei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140041/ https://www.ncbi.nlm.nih.gov/pubmed/32187978 http://dx.doi.org/10.3390/cancers12030698 |
Ejemplares similares
-
Synergistic Autophagy Effect of miR-212-3p in Zoledronic Acid-Treated In Vitro and Orthotopic In Vivo Models and in Patient-Derived Osteosarcoma Cells
por: Oh, Ju Yeon, et al.
Publicado: (2019) -
Correction: Oh, J.Y., et al. Synergistic Autophagy Effect of miR-212-3p in Zoledronic Acid-Treated In Vitro and Orthotopic In Vivo Models and in Patient-Derived Osteosarcoma Cells, Cancers 2019, 11, 1812
por: Oh, Ju Yeon, et al.
Publicado: (2020) -
Effects of carbon ion beam alone or in combination with cisplatin on malignant mesothelioma cells in vitro
por: Sai, Sei, et al.
Publicado: (2017) -
Combining carbon ion irradiation and non-homologous end-joining repair inhibitor NU7026 efficiently kills cancer cells
por: Ma, Hongyu, et al.
Publicado: (2015) -
Zoledronic acid is an effective radiosensitizer in the treatment of osteosarcoma
por: Kim, Eun Ho, et al.
Publicado: (2016)